Abstract
Ion mobility spectrometry coupled to a multi-capillary column (MCC/IMS) was used in anesthesia to detect signals related to Propofol in the breath directly. First time both positive and negative ions were investigated. It was found, that the detection limit in the negative mode is lower as in the positive one. Results of experiments with and without a bolus of Propofol were discussed with respect to kinetic models.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Eiceman GA, Karpas Z (2005) Ion mobility spectrometry, 2nd edn. CRC Press, Taylor & Francis, Boca Raton, p 350
Vautz W, Baumbach JI (2008) Analysis of bio-processes using ion mobility spectrometry. Eng Life Sci 8(1):19–25
O’Donnell RM, Harrington PdB, Sun X (2007) Applications of ion mobility spectrometry and differential mobility spectrometry in drug screening and quality control of pharmaceuticals
Baumbach JI, et al. (2010) Breath discovery based on ion mobility spectrometry and classification and differentiation models for lung diseases. Biomedizinische Technik 55(Suppl. 1)
Karpas Z et al (2002) Novel application for ion mobility spectrometry: diagnosing vaginal infections through measurement of biogenic amines. Anal Chim Acta 474(1–2):115–123
Vautz W, Baumbach JI (2008) Exemplar application of multi-capillary column ion mobility spectrometry for biological medical purpose. Int J Ion Mobility Spectrom 11(1):35–42
Smedsgaard J, Nielsen J (2005) Metabolite profiling of fungi and yeast: from phenotype to metabolome by MS and informatics. J Exp Bot 56(410):273–286
Maddula S (2005) Volatile metabolite fingerprints of Escherichia coli. In: Dept. of Biochemical and Chemical Engineering. University Dortmund, Dortmund. p. 52
Griffin JL, Kauppinen RA (2007) Tumour metabolomics in animal models of human cancer. J Proteome Res 6(2):498–505
Mieth M et al (2010) Automated needle trap heart-Cut GC/MS and needle trap comprehensive two-dimensional GC/TOF-MS for breath gas analysis in the clinical environment. Anal Chem 82(6):2541–2551
Buszewski B et al (2009) Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry. Biomed Chromatogr 23(5):551–556
Beauchamp J, Kirsch F, Buettner A (2010) Real-time breath gas analysis for pharmacokinetics: monitoring exhaled breath by on-line proton-transfer-reaction mass spectrometry after ingestion of eucalyptol-containing capsules. J Breath Res 4(Copyright (C) 2010 American Chemical Society (ACS). All Rights Reserved.): p. No pp. given
Herbig J et al (2009) On-line breath analysis with PTR-TOF. J Breath Res 3(2):027004/1–027004/10
Smith D et al (2010) Isoprene levels in the exhaled breath of 200 healthy pupils within the age range 7–18 years studied using SIFT-MS. J Breath Res 4(1):017101/1–017101/7
Seeley MJ et al (2009) In vitro SIFT-MS validation of a breath fractionating device using a model VOC and ventilation system. J Breath Res 3(016001):7. doi:10.1088/1752-7155/3/1/016001
Horvath I et al (2009) Exhaled biomarkers in lung cancer. Eur Respir J 34(1):261–275
Dragonieri S et al (2009) An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 64(2):166–170
Silkoff P (2008) History, technical and regulatory aspects of exhaled nitric oxide. J Breath Res 2(3):037001/1–037001/8
De Lacy Costello B et al (2008) An analysis of volatiles in the headspace of the faeces of neonates. J Breath Res 2(3):037023/1–037023/8
Davies AN, Baumbach JI (2008) Early lung cancer diagnostics by ion mobility spectrometry data handling. Spectrosc Eur 20(5):18–21
Bader S (2005) Atemluftüberwachung mittels mikrostrukturierter Ionenbeweglichkeitsspektrometrie: statistische Analyse zum Auffinden von Biomarkern für Lungenkrebs, In: Fachbereich Statistik. Universität Dortmund, Dortmund. p. 113
Westhoff M et al (2010) Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry. Int J Ion Mobility Spectrom 13(3–4):131–139
Baumbach JI, Westhoff M (2006) Ion mobility spectrometry to detect lung cancer and airway infections. Spectrosc Eur 18(6):22–27
Baumbach JI, et al. (2010) Metabolites in human breath during indursulfase therapy of a patient with hunter disease—first results of time series using MCC/IMS. Biomedizinische Technik 55(Suppl. 1)
Perl T et al (2009) Determination of serum propofol concentrations by breath analysis using ion mobility spectrometry. Br J Anaesth 103(6):822–827
Perl T, et al. (2010) Propofol in der Atemluft—MCC-Ionen mobilitäts spektrometrie propofol in expired air using MCC-ion mobility spectrometry. Biomedizinische Technik 55(Suppl. 1)
Dawidowicz AL et al (2000) The role of human lungs in the biotransformation of propofol. Anesthesiology 93(4):992–997
Borsdorf H, Mayer T, Zaresjousheghani M, Eiceman GA (2011) Recent developments in ion mobility spectrometry. Appl Spectrosc Rev 46:472–521
Marquez-Sillero I, Aguilera-Herrador E, Cardenas S, Valcarcel M (2011) Ion-mobility spectrometry for environmental analysis. Trac-Trends Anal Chem 30:677–690
Armenta S, Alcala M, Blanco M (2011) A review of recent, unconventional applications of ion mobility spectrometry (IMS). Anal Chim Acta 703:114–123
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kreuder, AE., Buchinger, H., Kreuer, S. et al. Characterization of propofol in human breath of patients undergoing anesthesia. Int. J. Ion Mobil. Spec. 14, 167–175 (2011). https://doi.org/10.1007/s12127-011-0080-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12127-011-0080-y